▫ Diabetes: +139%, successful Farxiga launch; good US Bydureon Pen uptake … is expected to significantly impact Synagis sales negatively in the fourth quarter … https://www.pharmalive.com/astrazeneca-2023-pushed-by-science/ Farxiga $4,381. The second best-seller was Farxiga, The drug made $4.38 billion, 46 percent more than in 2021. In the first half of 2023 sales … https://www.drugpatentwatch.com/p/alphasignals/tradename/FARXIGA A generic version of FARXIGA was approved as dapagliflozin by AIZANT on April 6th, 2026. What are the global sales for FARXIGA? significant … https://medicalinformation.astrazeneca-us.com/home/prescribing-information/farxiga.html FARXIGA® (dapagliflozin) prescribing information including indications, dosing and administration, contraindications and adverse event information. https://www.sec.gov/Archives/edgar/data/901832/000165495425001189/a1107w.htm Farxiga: sales milestones. Total Revenue of $22,353m in FY 2024 increased by 21% (24% at CER), representing 41% of overall Total Revenue (FY 2023: 40%). … https://greyb.com/blog/farxiga-patent-expiration/ The reason for its multi-million-dollar sales is its molecule patent. Despite its dominance in the market, Farxiga®/Forxiga® faces challenges as its molecule … https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2021/pdf/AstraZeneca_Patent_Expiries_of_Key_Marketed_Products_2021.pdf Farxiga/ Forxiga (dapagliflozin) recorded $94m of Collaboration Revenue. AstraZeneca has also recorded $400m of Collaboration Revenue https://www.drugpatentwatch.com/p/tradename/FARXIGA If FARXIGA revenue is approximately $5.8 billion globally, Net price reductions through rebates and payer contracting. https://www.fiercepharma.com/pharma/top-20-pharma-companies-2023-revenue … Farxiga, which brought in nearly $6 billion in sales. As Tagrisso suffered from price reductions in China and Japan, Farxiga benefited from … https://www.statista.com/statistics/1660807/astrazeneca-three-major-drug-sales-share/?srsltid=AU7gw4Uq-dc8uoXvl4GubbaBsWOSFEzH3n0saunv9aV4RbWsjCSuAQRC In 2025, Farxigo, Tagrisso, and Imfinzi were the three major products of AstraZeneca. The company reported a sales share of about 37 percent … https://endpoints.news/astrazeneca-auctions-off-more-assets-in-766m-deal-reports-positive-data-for-farxiga/ AstraZeneca auctions off more assets in $766M deal, reports positive data for Farxiga … That\’s a much smaller market, but an opening here could … https://www.farxiga.com/type-2-diabetes/savings-card *Eligible commercially insured patients can get Brand-Name FARXIGA for as low as $0 as long as their doctor prescribes it. Not available for government-insured … https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2021/pdf/AstraZeneca_Patent_Expiries_of_Key_Marketed_Products_2021.pdf Farxiga/. Forxiga. (dapagliflozin). A sodium-glucose cotransporter 2 (SGLT-2 … In addition to any product sales, AstraZeneca has also recorded $400m of … https://www.sec.gov/Archives/edgar/data/901832/000165495425001189/a1107w.htm Oncology Total Revenue of $22,353m in FY 2024 increased by 21% (24% at CER), representing 41% of overall Total Revenue (FY 2023: 40%). Collaboration Revenue was … https://www.farxiga.com/type-2-diabetes *Eligible commercially insured patients can get Brand-Name FARXIGA for as low as $0 as long as their doctor prescribes it. Not available for government-insured … https://www.midgardfinance.com/drugs/sales/ FarxigaDapagliflozin, AstraZeneca, Metabolic, 7,024, -5.6%, +1.3%. 16, Tagrisso … sales and land as contra-revenue. The largest by an order of magnitude is … https://www.farxiga-hcp.com/ FARXIGA® (dapagliflozin)—a brand-name SGLT2i treatment with clinical benefits for your patients with CKD, HF, and T2D1. Trusted for more than a decade2*. https://www.pharmalive.com/astrazeneca-2023-pushed-by-science/ The drug made $4.38 billion, 46 percent more than in 2021. In the first half of 2023 sales were $2.8 billion, 33 percent more than in the first … https://www.sec.gov/Archives/edgar/data/1121404/000119312521157110/d924287dex991.htm First-quarter 2021 Pharmaceutical sales increased 3.8% to €6,563 million, with double-digit growth of the Specialty Care portfolio mainly driven by the strong … https://en.wikipedia.org/wiki/Annual_pharmaceutical_drug_sales This is a list of annual sales of patented medications per pharmaceutical group. Because it derives from 10-K data, drugs that have passed loss of … https://www.novartis.com/investors/financial-data/product-sales Full year 2025 product sales. The following table provides the top 20 product net sales … Net sales from continuing operations reflect Fabhalta sales for all … https://trumprx.gov/p/farxiga Find the world\’s lowest prices for Farxiga® with Most-Favored-Nation pricing on TrumpRx. Starting at $35.00. https://www.drugs.com/farxiga.html Farxiga (dapagliflozin) is used to treat type 2 diabetes, heart failure, or chronic kidney disease. It is taken once a day. Learn about uses, side effects, … https://www.drugs.com/history/farxiga.html FDA Approved: Yes (First approved January 8, 2014) ; Brand name: Farxiga ; Generic name: dapagliflozin ; Dosage form: Tablets ; Company: AstraZeneca https://finance.yahoo.com/news/astrazenecas-farxiga-gets-fast-track-152803678.html Farxiga/Forxiga, a key top-line driver of AstraZeneca, generated sales of $407 million in the first quarter of 2020, representing 19% growth … https://www.farxiga.com/savings-support/cost *Eligible commercially insured patients can get Brand-Name FARXIGA for as low as $0 as long as their doctor prescribes it. Not available for government-insured … https://www.biopharmadive.com/news/astrazeneca-2030-goal-cancer-drugs-oncology-strategy/716756/ AstraZeneca\’s plan to reach $80 billion in sales by 2030 relies heavily on a slate of roughly one dozen cancer drugs it expects will become … https://www.ucb.com/newsroom/press-releases/article/on-growth-path-for-a-decade-plus-strong-launch-execution-driving-company-growth Revenue in 2024 increased to € 6.15 billion, a plus of 17% (+19% CER1),; Net sales were up by 15% to € 5.61 billion (+17% CER1) driven by a … https://archive.kyivpost.com/business/pharmaceutical-sales-reach-3-4-billion-producers-call-for-limited-antibiotic-use.html Medication sales reached $4.2 billion in 2020, increasing by 4.7% year over year, even though the actual number of drugs sold went down.